Twist Bioscience/$TWST
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Twist Bioscience
Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.
Ticker
$TWST
Sector
Primary listing
Employees
979
Headquarters
Website
Twist Bioscience Metrics
BasicAdvanced
$2.7B
-
-$1.27
2.27
-
Price and volume
Market cap
$2.7B
Beta
2.27
52-week high
$57.88
52-week low
$23.30
Average daily volume
1.4M
Financial strength
Current ratio
3.778
Quick ratio
3.083
Long term debt to equity
22.102
Total debt to equity
24.787
Profitability
EBITDA (TTM)
-112.748
Gross margin (TTM)
51.62%
Net profit margin (TTM)
-19.56%
Operating margin (TTM)
-34.35%
Effective tax rate (TTM)
-1.16%
Revenue per employee (TTM)
$400,000
Management effectiveness
Return on assets (TTM)
-13.49%
Return on equity (TTM)
-16.79%
Valuation
Price to revenue (TTM)
6.664
Price to book
5.81
Price to tangible book (TTM)
7.35
Price to free cash flow (TTM)
-30.087
Free cash flow yield (TTM)
-3.32%
Free cash flow per share (TTM)
-1.439
Growth
Revenue change (TTM)
18.59%
Earnings per share change (TTM)
-62.38%
3-year revenue growth (CAGR)
21.97%
3-year earnings per share growth (CAGR)
-30.94%
What the Analysts think about Twist Bioscience
Analyst ratings (Buy, Hold, Sell) for Twist Bioscience stock.
Twist Bioscience Financial Performance
Revenues and expenses
Twist Bioscience Earnings Performance
Company profitability
Twist Bioscience News
AllArticlesVideos
Twist Bioscience Launches Next-Generation Library Preparation Kits Powered by Proprietary Enzymes
Business Wire·1 month ago
These Analysts Increase Their Forecasts On Twist Bioscience After Q1 Results
Benzinga·1 month ago
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Business Wire·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Twist Bioscience stock?
Twist Bioscience (TWST) has a market cap of $2.7B as of March 14, 2026.
What is the P/E ratio for Twist Bioscience stock?
The price to earnings (P/E) ratio for Twist Bioscience (TWST) stock is 0 as of March 14, 2026.
Does Twist Bioscience stock pay dividends?
No, Twist Bioscience (TWST) stock does not pay dividends to its shareholders as of March 14, 2026.
When is the next Twist Bioscience dividend payment date?
Twist Bioscience (TWST) stock does not pay dividends to its shareholders.
What is the beta indicator for Twist Bioscience?
Twist Bioscience (TWST) has a beta rating of 2.27. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.